Skip to main content
VCbacked
Log inGet Started

CorFlow Therapeutics

Baar, Switzerland

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.

$48.5M raised
Sep 2024
Series B
BiotechnologyManufacturingMedicalMedical Device

Top Investors

Wellington PartnersMérieux Equity PartnersMonte Carlo CapitalPanakes Partners415 Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CorFlow Therapeutics

How much funding has CorFlow Therapeutics raised?
CorFlow Therapeutics has raised $48.5M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
Who are CorFlow Therapeutics's investors?
CorFlow Therapeutics's investors include Wellington Partners, Mérieux Equity Partners, Monte Carlo Capital, Panakes Partners, 415 Capital.
Where is CorFlow Therapeutics headquartered?
CorFlow Therapeutics is headquartered in Baar, Switzerland.
What does CorFlow Therapeutics do?
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.
What stage is CorFlow Therapeutics at?
CorFlow Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CorFlow Therapeutics — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/corflow-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). CorFlow Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/corflow-therapeutics
Wikipedia (cite web)
{{cite web |title=CorFlow Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/corflow-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K